Marker Therapeutics (MRKR) Notes Payables (2010 - 2019)
Marker Therapeutics (MRKR) posted quarterly Notes Payables of $31000.0 for Q4 2019, down 36.73% year-over-year from $49000.0 in Q4 2018, and down 75.97% quarter-over-quarter from $129000.0 in Q3 2019.
Marker Therapeutics (MRKR) Notes Payables (2010 - 2019) Analysis & Trends
Marker Therapeutics (MRKR) has reported Notes Payables for 10 consecutive years, with $31000.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Notes Payables fell 36.73% year-over-year to $31000.0; the TTM figure through Dec 2019 stood at $31000.0 (down 36.73% YoY), while the FY2019 annual figure was $31000.0, down 36.73% from the prior year.
- Notes Payables fell to $31000.0 in Q4 2019 per MRKR's latest filing, from $129000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $70.0 million in Q2 2015 and bottomed at $5000.0 in Q1 2016.
- Historically, Notes Payables has averaged $6.9 million across 5 years, with a median of $7000.0 in 2016.
- Annual changes were most pronounced in 2015 — Notes Payables surged 281291.4% — and 2016, when it tumbled 99.99%.
- Marker Therapeutics' Notes Payables stood at $26.5 million in 2015, then tumbled by 99.98% to $5000.0 in 2016, then soared by 80.0% to $9000.0 in 2017, then surged by 444.44% to $49000.0 in 2018, then slumped by 36.73% to $31000.0 in 2019.
- Business Quant data shows MRKR's Notes Payables at $31000.0 in Q4 2019, $129000.0 in Q3 2019, and $65000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Marker Therapeutics | 23.95 Mn | 12.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 31,000.00 |
| Sep 30, 2019 | 129,000.00 |
| Jun 30, 2019 | 65,000.00 |
| Mar 31, 2019 | 58,000.00 |
| Dec 31, 2018 | 49,000.00 |
| Sep 30, 2018 | 5,000.00 |
| Jun 30, 2018 | 5,000.00 |
| Mar 31, 2018 | 5,000.00 |
| Dec 31, 2017 | 9,000.00 |
| Sep 30, 2017 | 5,000.00 |
| Jun 30, 2017 | 5,000.00 |
| Mar 31, 2017 | 5,000.00 |
| Dec 31, 2016 | 5,000.00 |
| Sep 30, 2016 | 5,000.00 |
| Jun 30, 2016 | 5,000.00 |
| Mar 31, 2016 | 5,000.00 |
| Dec 31, 2015 | 26.49 Mn |
| Sep 30, 2015 | 32.20 Mn |
| Jun 30, 2015 | 69.96 Mn |
| Mar 31, 2015 | 8.99 Mn |